IPO

Leading manufacturer GEVORKYAN is launching its first ESOP, a strategic move to retain key talent and drive growth in the competitive powder metallurgy market.

After a second bankruptcy filing in five years, the 25-year-old fashion chain is closing for good, sparking huge sales and questions about its collapse.

Key Mining Corp. is going public via a SPAC deal to fund a massive titanium project in Chile, betting on rising demand for critical minerals.

Cantor Fitzgerald launches its 15th SPAC, raising $115M. With the market rebounding, will this bet on tech and healthcare pay off for investors?

Forgent Power Solutions saw a strong NYSE debut, but with IPO funds paying back its PE owner, is this a growth story or a private equity cash-out?

The veteran SPAC sponsor closes an upsized IPO for its eighth fund, targeting industrial tech and energy transition with a unique warrant-free structure.

Pan-European exchange reports a strong start to 2026, fueled by a historic defense IPO and a dramatic spike in foreign exchange and metals trading.

Inspired Entertainment launches STRATA, a cloud-native platform set to disrupt the lottery industry with unprecedented scalability, security, and flexibility.

A small-cap food company plans a major NASDAQ leap, but its future hinges on a secret 'clean' technology. Can this ambitious, risky pivot succeed?

Strong investor demand boosts financing for BC's Golden Triangle exploration, highlighting Canada's strategic push into the critical minerals sector.

With a new celebrity ad, CoreWeave is making a play for AI dominance. But can its specialized tech overcome financial risks and challenge industry giants?

Aucta Pharma launches two rare disease drugs, PYQUVI and ZELVYSIA, betting on a 'branded-generic' model to navigate highly competitive markets.

Industrial conglomerate Schouw & Co. offers a fee for bondholder consent to spin off its aquaculture giant BioMar, a move that could unlock value but alters risk.

China's top pig farmer, Muyuan Foods, raises HK$10.7B in a landmark Hong Kong IPO, fueling a high-tech global expansion into Southeast Asia and beyond.

Canadian biotech Satellos Bioscience seeks a Nasdaq listing and a $50M public offering to advance its promising muscle regeneration drug for Duchenne.

AI-powered reAlpha has launched a new platform to unify the fragmented homebuying journey. Can its integrated approach truly simplify the process for buyers?

After a blockbuster IPO raised nearly $300 million, dermatologist-founded Veradermics is poised to challenge the hair loss market with its new oral pill.

Colombier Acquisition Corp. III, with a board of political and tech heavyweights, has a $299M war chest. Its hunt for a 'patriotic' target begins.

Fidelity sweeps top honors in Corporate Insight’s annual awards, highlighting a fierce digital arms race with Schwab and E*TRADE to win over modern investors.

Global internet leaders convene in Mumbai for ICANN85 to launch new domains and defend a unified web in a pivotal moment for digital governance.